References
- Arnold K, Bordoli L, Kopp J, Schwede T. (2006). The SWISS-MODEL workspace: A web-based environment for protein structure homology modelling. Bioinformatics 22:195–201
- Beaulieu M, Lévesque E, Hum DW, Bélanger A. (1998). Isolation and characterization of a human orphan UDP-glucuronosyltransferase, UGT2B11. Biochem Biophys Res Commun 248:44–50
- Bosio A, Binczek E, Le Beau MM, et al. (1996). The human gene CGT encoding the UDP-galactose ceramide galactosyl transferase (cerebroside synthase): Cloning, characterization, and assignment to human chromosome 4, band q26. Genomics 34:69–75
- Brazier-Hicks M, Offen WA, Gershater MC, et al. (2007). Characterization and engineering of the bifunctional N- and O-glucosyltransferase involved in xenobiotic metabolism in plants. Proc Natl Acad Sci USA 104:20238–20243
- Burchell B, Blanckaert N. (1984). Bilirubin mono- and di-glucuronide formation by purified rat liver microsomal bilirubin UDP-glucuronyltransferase. Biochem J 223:461–465
- Carçabal P, Jockusch RA, Hünig I, et al. (2005). Hydrogen bonding and cooperativity in isolated and hydrated sugars: Mannose, galactose, glucose, and lactose. J Am Chem Soc 127:11414–11425
- Chau N, Elliot DJ, Lewis BC, et al. (2014). Morphine glucuronidation and glucosidation represent complementary metabolic pathways that are both catalyzed by UDP-glucuronosyltransferase 2B7: Kinetic, inhibition, and molecular modeling studies. J Pharmacol Exp Ther 349:126–137
- Chen G, Blevins-Primeau AS, Dellinger RW, et al. (2007). Glucuronidation of nicotine and cotinine by UGT2B10: Loss of function by the UGT2B10 Codon 67 (Asp > Tyr) polymorphism. Cancer Res 67:9024–9029
- Chen G, Dellinger RW, Sun D, et al. (2008). Glucuronidation of tobacco-specific nitrosamines by UGT2B10. Drug Metab Dispos 36:824–830
- Clarke C, Woods RJ, Gluska J, et al. (2001). Involvement of water in carbohydrate-protein binding. J Am Chem Soc 23:12238–12247
- DeLano W. (2002). The PyMOL molecular graphics system. San Carlos, CA: DeLano Scientific
- Ekroos M, Sjögren T. (2006). Structural basis for ligand promiscuity in cytochrome P450 3A4. Proc Natl Acad Sci USA 103:13682–13687
- Fevery J, Van de Vijver M, Michiels R, Heirwegh KP. (1977). Comparison in different species of biliary bilirubin-IX alpha conjugates with the activities of hepatic and renal bilirubin-IX alpha-uridine diphosphate glycosyltransferases. Biochem J 164:737–746
- Hu Y, Walker S. (2002). Remarkable structural similarities between diverse glycosyltransferases. Chem Biol 9:1287–1296
- Jin CJ, Miners JO, Lillywhite KJ, Mackenzie PI. (1993). cDNA cloning and expression of two new members of the human liver UDP-glucuronosyltransferase 2B subfamily. Biochem Biophys Res Commun 194:496–503
- Jockusch RA, Kroemer RT, Talbot FO, et al. (2004). Probing the glycosidic linkage: UV and IR ion-dip spectroscopy of a lactoside. J Am Chem Soc 126:5709–5714
- Junge F, Schneider B, Reckel S, et al. (2008). Large-scale production of functional membrane proteins. Cell Mol Life Sci 65:1729–1755
- Kaivosaari S, Toivonen P, Hesse LM, et al. (2007). Nicotine glucuronidation and the human UDP-glucuronosyltransferase UGT2B10. Mol Pharmacol 72:761–768
- Kato Y, Izukawa T, Oda S, et al. (2013). Human UDP-glucuronosyltransferase (UGT) 2B10 in drug N-glucuronidation: Substrate screening and comparison with UGT1A3 and UGT1A4. Drug Metab Dispos 41:1389–1397
- Kerdpin O, Mackenzie PI, Bowalgaha K, et al. (2009). Influence of N-terminal domain histidine and proline residues on the substrate selectivities of human UDP-glucuronosyltransferase 1A1, 1A6, 1A9, 2B7, and 2B10. Drug Metab Dispos 37:1948–1955
- Korprasertthaworn P, Rowland A, Lewis BC, et al. (2012). Effects of amino acid substitutions at positions 33 and 37 on UDP-glucuronosyltransferase 1A9 (UGT1A9) activity and substrate selectivity. Biochem Pharmacol 84:1511–1521
- Kubota T, Lewis BC, Elliot DJ, et al. (2007). Critical roles of residues 36 and 40 in the phenol and tertiary amine aglycone substrate selectivities of UDP-glucuronosyltransferases 1A3 and 1A4. Mol Pharmacol 72:1054–1062
- Larson ET, Deng W, Krumm BE, et al. (2008). Structures of substrate- and inhibitor-bound adenosine deaminase from a human malaria parasite show a dramatic conformational change and shed light on drug selectivity. J Mol Biol 381:975–988
- Lévesque E, Turgeon D, Carrier JS, et al. (2001). Isolation and characterization of the UGT2B28 cDNA encoding a novel human steroid conjugating UDP-glucuronosyltransferase. Biochemistry 40:3869–3881
- Lewis BC, Mackenzie PI, Elliot DJ, et al. (2007). Amino terminal domains of human UDP-glucuronosyltransferases (UGT) 2B7 and 2B15 associated with substrate selectivity and autoactivation. Biochem Pharmacol 73:1463–1473
- Mackenzie P, Little JM, Radominska-Pandya A. (2003). Glucosidation of hyodeoxycholic acid by UDP-glucuronosyltransferase 2B7. Biochem Pharmacol 65:417–421
- Mackenzie PI. (1990). Expression of chimeric cDNAs in cell culture defines a region of UDP glucuronosyltransferase involved in substrate selection. J Biol Chem 265:3432–3435
- Mackenzie PI, Bock KW, Burchell B, et al. (2005). Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily. Pharmacogenet Genomics 15:677–685
- Mackenzie PI, Owens IS, Burchell B, et al. (1997). The UDP glycosyltransferase gene superfamily: Recommended nomenclature update based on evolutionary divergence. Pharmacogenetics 7:255–269
- Mackenzie PI, Rogers A, Treloar J, et al. (2008). Identification of UDP glycosyltransferase 3A1 as a UDP N-acetylglucosaminyltransferase. J Biol Chem 283:36205–36210
- Meech R, Mackenzie PI. (1998). Determinants of UDP glucuronosyltransferase membrane association and residency in the endoplasmic reticulum. Arch Biochem Biophys 356:77–85
- Meech R, Mubarokah N, Shivasami A, et al. (2015). A novel function for UDP glycosyltransferase 8: Galactosidation of bile acids. Mol Pharmacol 87:442–450
- Meech R, Miners JO, Lewis BC, Mackenzie PI. (2012a). The glycosidation of xenobiotics and endogenous compounds: Versatility and redundancy in the UDP glycosyltransferase superfamily. Pharmacol Ther 134:200–218
- Meech R, Rogers A, Zhuang L, et al. (2012b). Identification of residues that confer sugar selectivity to UDP-glycosyltransferase 3A (UGT3A) enzymes. J Biol Chem 287:24122–24130
- Miley MJ, Zielinska AK, Keenan JE, et al. (2007). Crystal structure of the cofactor-binding domain of the human phase II drug-metabolism enzyme UDP-glucuronosyltransferase 2B7. J Mol Biol 369:498–511
- Naidoo KJ, Chen JYJ. (2003). The role of water in the design of glycosidic linkage flexibility. Mol Phys 101:2687–2694
- Nishiyama T, Kobori T, Arai K, et al. (2006). Identification of human UDP-glucuronosyltransferase isoform(s) responsible for the C-glucuronidation of phenylbutazone. Arch Biochem Biophys 454:72–79
- Offen W, Martinez-Fleites C, Yang M, et al. (2006). Structure of a flavonoid glucosyltransferase reveals the basis for plant natural product modification. EMBO J 25:1396–1405
- Osmani SA, Bak S, Imberty A, et al. (2008). Catalytic key amino acids and UDP-sugar donor specificity of a plant glucuronosyltransferase, UGT94B1: Molecular modeling substantiated by site-specific mutagenesis and biochemical analyses. Plant Physiol 148:1295–1308
- Osmani SA, Bak S, Møller BL. (2009). Substrate specificity of plant UDP-dependent glycosyltransferases predicted from crystal structures and homology modeling. Phytochemistry 70:325–347
- Parra RD, Bulusu S, Zeng XC. (2003). Cooperative effects in one-dimensional chains of three-center hydrogen bonding interactions. J Chem Phys 118:3499–3509
- Privé GG. (2007). Detergents for the stabilization and crystallization of membrane proteins. Methods 41:388–397
- Quiocho FA, Wilson DK, Vyas NK. (1989). Substrate specificity and affinity of a protein modulated by bound water molecules. Nature 340:404–407
- Radominska-Pandya A, Bratton SM, Redinbo MR, Miley MJ. (2010). The crystal structure of human UDP-glucuronosyltransferase 2B7 C-terminal end is the first mammalian UGT target to be revealed: The significance for human UGTs from both the 1A and 2B families. Drug Metab Rev 42:133–144
- Sattelle BM, Almond A. (2011). Is N-acetyl-D-glucosamine a rigid 4C1 chair? Glycobiology 21:1651–1662
- Senafi SB, Clarke DJ, Burchell B. (1994). Investigation of the substrate specificity of a cloned expressed human bilirubin UDP-glucuronosyltransferase: UDP-sugar specificity and involvement in steroid and xenobiotic glucuronidation. Biochem J 303:233–240
- Shao H, He X, Achnine L, et al. (2005). Crystal structures of a multifunctional triterpene/flavonoid glycosyltransferase from Medicago truncatula. Plant Cell 17:3141–3154
- Tang C, Ma B. (2005). Glycosidation of an endothelin ET(A) receptor antagonist and diclofenac in human liver microsomes: Aglycone-dependent UDP-sugar selectivity. Drug Metab Dispos 33:1796–1802
- Toide K, Terauchi Y, Fujii T, et al. (2004). Uridine diphosphate sugar-selective conjugation of an aldose reductase inhibitor (AS-3201) by UDP-glucuronosyltransferase 2B subfamily in human liver microsomes. Biochem Pharmacol 67:1269–1278
- Turton K, Natesh R, Thiyagarajan N, et al. (2004). Crystal structures of Erythrina cristagalli lectin with bound N-linked oligosaccharide and lactose. Glycobiology 14:923–929
- Wagner S, Bader ML, Drew D, de Gier JW. (2006). Rationalizing membrane protein overexpression. Trends Biotechnol 24:364–371